Compare UAN & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UAN | STAA |
|---|---|---|
| Founded | 2007 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2008 | 1995 |
| Metric | UAN | STAA |
|---|---|---|
| Price | $135.38 | $22.65 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $22.81 |
| AVG Volume (30 Days) | 29.6K | ★ 874.6K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 7.91% | N/A |
| EPS Growth | ★ 61.98 | N/A |
| EPS | ★ 12.06 | 0.26 |
| Revenue | ★ $606,038,000.00 | $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ $11.04 | $90.85 |
| Revenue Growth | ★ 15.36 | N/A |
| 52 Week Low | $86.43 | $15.59 |
| 52 Week High | $139.50 | $35.87 |
| Indicator | UAN | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 69.00 | 47.81 |
| Support Level | $120.76 | $23.27 |
| Resistance Level | $139.42 | $24.26 |
| Average True Range (ATR) | 2.55 | 0.82 |
| MACD | 0.76 | 0.17 |
| Stochastic Oscillator | 92.51 | 70.13 |
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.